RxDoctor Payments Data

Giacomo Folden, DO

Family Medicine · Mount Clemens, MINPI 1215310073

Payments from drug & device makers

$1,363in general payments, 2019–2025

Across 71 payments — averaging $19.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$233
  • Amgen$216
  • Novo Nordisk$179
  • Astellas Pharma US Inc$175
  • Exact Sciences$154
  • Otsuka America Pharmaceutical, Inc.$61
  • plus $346 from 12 others

What the payments were for

  • Food & beverage$1,26893%
  • Education$957%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,363 in reported general payments places this provider in the 75th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$55,438
Medicare patients
158
Services billed
749

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide40$45,865
FarxigaDapagliflozin Propanediol23$30,291
JardianceEmpagliflozin26$29,529
TrulicityDulaglutide15$18,914
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$17,464
MounjaroTirzepatide12$16,291
JanuviaSitagliptin Phosphate17$14,785
Repatha SureclickEvolocumab22$11,775
XareltoRivaroxaban14$10,533
EliquisApixaban12$9,579
Fluticasone-SalmeterolFluticasone Propion/Salmeterol15$3,964
Atorvastatin Calcium252$3,263
Methylphenidate ErMethylphenidate Hcl11$2,283
Omeprazole149$1,946
Potassium Chloride11$1,875

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$179$45,86540 claims
Lilly USA, LLCTrulicity, Mounjaro$47$35,20527 claims
GSKTrelegy Ellipta$47$17,46416 claims
MerckJanuvia$25$14,78517 claims
PfizerEliquis$233$9,57912 claims
AbbVieSynthroid$15$85914 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Mount Clemens

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →